Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the…
NEW YORK (Reuters Health) – Since the mid-90s, early survival rates after allogeneic hematopoietic cell transplantation (alloHCT) among patients with hematologic diseases have improved significantly, based on an…
By Robert Saunders NEW YORK (Reuters Health) – For men with biochemical recurrence of prostate cancer after radical prostatectomy, radiation offers a good chance of cure, according to…
NEW YORK (Reuters Health) – Fidaxomicin, approved by the US Food and Drug Administration in 2011 for the treatment of Clostridium difficile-associated diarrhea, is particularly effective in cancer…
By Robert Saunders NEW YORK (Reuters Health) – When papillary thyroid cancer spreads to lymph nodes in the neck, percutaneous laser ablation may spare patients further invasive surgery.…
NEW YORK (Reuters Health) – In colorectal cancer patients, ablation of bilateral hepatic metastases with or without surgery compares well to the gold standard approach of bilateral resection,…
NEW YORK (Reuters Health) – Based on Medicare claims data, the rate of incisional hernia following radical prostatectomy is about three-times higher with minimally invasive surgery than with…
By Genevra Pittman NEW YORK (Reuters Health) – Men who were exposed to Agent Orange chemicals during the Vietnam War are at higher risk for high-grade prostate cancer…
By Megan Brooks NEW YORK (Reuters Health) – Radiation may be unnecessary for some women with early-stage breast cancer after conservative surgery, according to preliminary data from a…
NEW YORK (Reuters Health) – Duloxetine can be helpful in cancer patients who experience painful neuropathy as a sequela of treatment with neurotoxic antineoplastic agents, according to a…
NEW YORK (Reuters Health) – Over half of patients with refractory and relapsed acute lymphocytic leukemia (ALL) achieve a complete or partial response when treated with the CD22…
